Dr. Eric Westman discusses the importance of monitoring patients on the keto diet, especially those who are on specific medications. The focus is on the potential complications when combining medications like SGLT2 inhibitors with a ketogenic diet.

SGLT2 inhibitors, commonly prescribed for heart failure and diabetes, may pose risks when paired with a keto diet. These medications cause the body to excrete glucose through urine, hence possibly leading to urinary infections or more serious conditions like metabolic acidosis if not managed properly.

While keto diets have shown promising results in weight loss and managing diabetes and heart conditions, Dr. Westman stresses caution and the importance of medical supervision, particularly when other conditions or unusual medications are involved.

The ketogenic diet is recognized for its potential benefits in managing and sometimes reversing chronic conditions beyond weight management.

Recent studies indicate that the keto diet could be beneficial for certain cancers. Specifically, anaplastic thyroid carcinoma research suggests that low-carbohydrate diets might impede tumor growth, offering another potential therapeutic avenue, though more research is needed.

A key point highlighted by Dr. Westman is the focus on shifting from simply treating cholesterol levels with medication to more comprehensive management strategies, including dietary approaches.

Cholesterol is not a disease; atherosclerosis is the target to prevent.

He argues for a more individualized approach, utilizing imaging and other assessments to evaluate true cardiovascular risk rather than relying solely on cholesterol medication.